Form 4: Avid Bioservices Director Esther M. Alegria Reports Stock Unit Vesting

Sentiment:

SEC Form 4


Director Esther M. Alegria reports vesting of restricted stock units in Avid Bioservices, Inc.

Summary

  • On July 9, 2024, Esther M. Alegria, a director of Avid Bioservices, Inc., had 689 restricted stock units vest.
  • These units, granted on July 9, 2021, vested in three equal annual installments starting July 9, 2022, and ending July 9, 2024.
  • Upon vesting, each unit represents the right to receive one share of Avid Bioservices' common stock.
  • Following the transaction, Ms. Alegria directly owns 26,756 derivative securities.

Sentiment

Score: 5

Explanation: This is a neutral report on stock unit vesting, a routine part of executive compensation.

Industry Context

This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It provides transparency regarding the equity holdings of company insiders.

Stakeholder Impact

  • The vesting of restricted stock units may have a minor dilutive effect on existing shareholders.

Key Dates

DateDescription
07/09/2021Restricted Stock Units granted to the reporting person
07/09/2022First vesting date of the Restricted Stock Units
07/09/2024Final vesting date of the Restricted Stock Units and transaction date
07/11/2024Date of report

Keywords

Avid Bioservices, Director, Esther M. Alegria, Restricted Stock Units, Vesting, CDMO, Form 4, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.